How to Achieve Digital Pharma Marketing Results: Dealing with Disruption
This article focuses on digital disruption, which is the focus of a chapter in the book RESULTS: The Future of Pharmaceutical and Healthcare Marketing written by by R.J. Lewis (aka RJ) et al.
DTC Ad Spending Rises From the Grave: Pfizer Leads the Ghoulish Pack
This article presents the data and discusses Pfizer's leading role in the DTC ad resurgence, especially in regard to TV advertising, which accounts for almost 70% of all DTC advertising dollars.
The Consumer Brief Summary: FDA’s New Thinking Regarding Risk Communication
New FDA guidelines jettison the 'traditional approach' to fulfilling the brief summary requirement and replaces it with what the FDA calls the 'Consumer Brief Summary.' This article summarizes the new guidelines and reviews the need for additional guidelines that specifically address the fair balance section of DTC print ads.
Pharma Marketing News Vol. 14, No. 2: February 2015
Welcome to Vol. 14, Issue No. 2 (FEBRUARY 2015) of Pharma Marketing News. The FDA is a hot topic in this issue. Specifically, it's new thinking on presenting risk information in direct-to-consumer print ads. Are the new guidelines relevant for online advertising?
2015 New Year’s Resolutions for Pharma: Focus on Mobile, DTC, Patients, Prices, etc.
Here's John Mack's list of 2015 resolutions for pharmaceutical marketers. Hopefully, at least one of these will be kept, although no one is making any promises.
Pharma Marketing News Vol. 14, No. 7: December 2015
Welcome to Vol. 14, Issue No. 7 (DECEMBER 2015) of Pharma Marketing News. DTC Ban Revisited, Digital Disruption, Best of 2015, are the themes of this issue.
Pharma’s Use of Medical Conference Twitter Hashtags: Is It “Backchannel” Promotion That Needs to...
This article discusses the pros and cons of safeguards proposed a group of academic physicians (the #MICEproject) to limit pharmaceutical 'detailing' and to 'bring the medical community closer to establishing guidelines for third party activities in Twitter back-channels.'
PharmaPhobia & What to Do About It: Tom Stossel Attempts to Debunk the Conflict-of-Interest...
Will Tom Stossel's new book title PHARMAPHOBIA, which ends with a section on 'What is to be done,' turn the tide as he hopes it will? This article reviews some of Stossel's main arguments. You be the judge.
The Next FDA Commissioner Will Be… Industry Pundits Think It’s a Shoe-In. Do You?
In a new survey, Pharma Marketing News asks your opinion about who should be the next FDA commissioner.
The survey has been seeded with the candidates mentioned in this article. You can choose one of these or enter your own choice.
Pharma Marketing: The Year 2015 in Images
Pharmaguy's Favorite Images with Commentary from Pharma Marketing Blog, Pharma Marketing News, and Scoops
